Irini Lazou Ahrén

Title: Irini Lazou Ahrén: Innovator in Probiotic Applications

Introduction

Irini Lazou Ahrén is a prominent inventor based in Lund, Sweden. She has made significant contributions to the field of probiotics, particularly in relation to celiac disease and osteoporosis. With a total of two patents to her name, Ahrén is recognized for her innovative approaches to health and nutrition.

Latest Patents

Ahrén's latest patents include methods for addressing celiac disease using specific lactobacillus strains. This invention focuses on the use of probiotic strains to prevent and treat celiac disease autoimmunity (CDA) and celiac disease (CD). A preferred composition involves a combination of strains, particularly 8700:2 (DSM 13434) and HEAL 9 (DSM 15312). Additionally, she has developed probiotic strains aimed at the treatment or prevention of osteoporosis. This invention utilizes a combination of paracasei and plantarum strains to enhance calcium absorption in mammals, especially humans.

Career Highlights

Ahrén is currently associated with Probi AB, a company dedicated to advancing probiotic research and applications. Her work has positioned her as a key figure in the development of innovative health solutions.

Collaborations

Throughout her career, Ahrén has collaborated with notable colleagues, including Daniel Agardh and Lars Niklas Larsson. These partnerships have contributed to her success in the field of probiotics.

Conclusion

Irini Lazou Ahrén's contributions to probiotic research highlight her role as an influential inventor in the health sector. Her innovative patents demonstrate the potential of probiotics in treating significant health issues.